Recognition of protease by HIV-1-specific cytotoxic T-lymphocyte is influenced by protease inhibitor resistance mutations

被引:0
|
作者
Mueller, S. M. [1 ,2 ]
Schatz, B. [1 ,2 ]
Eismann, K. [3 ]
Bergmann, S. [3 ]
Walter, H. [4 ]
Schmidt, B. [4 ]
Korn, K. [4 ]
Schmucker, M. [1 ,2 ]
Spriewald, B. [4 ]
Harrer, E. [4 ]
Harrer, T. [1 ,2 ]
机构
[1] Univ Erlangen Nurnberg, Dept Internal Med, Erlangen, Germany
[2] Univ Erlangen Nurnberg, Dept Internal Med, Erlangen, Germany
[3] Univ Erlangen Nurnberg, Inst Clin Immunol, Erlangen, Germany
[4] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, Erlangen, Germany
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:A89 / A89
页数:1
相关论文
共 50 条
  • [41] Combining mutations in HIV-1 protease to understand mechanisms of resistance
    Mahalingam, B
    Boross, P
    Wang, YF
    Louis, JM
    Fischer, CC
    Tozser, J
    Harrison, RW
    Weber, IT
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2002, 48 (01) : 107 - 116
  • [42] In vivo migration and function of transferred HIV-1-specific cytotoxic T cells
    Brodie, SJ
    Lewinsohn, DA
    Patterson, BK
    Jiyamapa, D
    Krieger, J
    Corey, L
    Greenberg, PD
    Riddell, SR
    NATURE MEDICINE, 1999, 5 (01) : 34 - 41
  • [43] High prevalence of bevirimat resistance mutations in protease inhibitor-resistant HIV isolates
    Verheyen, Jens
    Verhofstede, Chris
    Knops, Elena
    Vandekerckhove, Linos
    Fun, Axel
    Brunen, Diede
    Dauwe, Kenny
    Wensing, Annemarie M. J.
    Pfister, Herbert
    Kaiser, Rolf
    Nijhuis, Monique
    AIDS, 2010, 24 (05) : 669 - 673
  • [44] ANALYSIS OF THE ANTIVIRAL CYTOTOXIC T-LYMPHOCYTE RESPONSE IN PRIMARY HIV-1
    BORROW, P
    LEWICKI, H
    HORWITZ, M
    HAHN, BH
    SHAW, GM
    OLDSTONE, MBA
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 309 - 309
  • [45] Cytotoxic T-lymphocyte responses to HIV-1 reverse transcriptase (review)
    Menéndez-Arias, L
    Mas, A
    Domingo, E
    VIRAL IMMUNOLOGY, 1998, 11 (04) : 167 - 181
  • [46] HIV-specific cytotoxic T-lymphocyte activity in immunologically normal HIV-infected persons
    Bernard, NF
    Pederson, K
    Chung, F
    Ouellet, L
    Wainberg, MA
    Tsoukas, CM
    AIDS, 1998, 12 (16) : 2125 - 2139
  • [47] HMG2 interacts with the nucleosome assembly protein SET and is a target of the cytotoxic T-lymphocyte protease granzyme A
    Fan, ZS
    Beresford, PJ
    Zhang, D
    Lieberman, J
    MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (08) : 2810 - 2820
  • [48] Impact of gag mutations on selection of darunavir resistance mutations in HIV-1 protease
    Marcelin, A. G.
    Lambert-Niclot, S.
    Canestri, A.
    Soulie, C.
    Wirden, M.
    Tubiana, R.
    Cheret, A.
    Katlama, C.
    Flandre, P.
    Calvez, V.
    ANTIVIRAL THERAPY, 2008, 13 (04) : A51 - A51
  • [49] Impact of gag mutations on selection of darunavir resistance mutations in HIV-1 protease
    Lambert-Niclot, Sidonie
    Flandre, Philippe
    Malet, Isabelle
    Canestri, Ana
    Soulie, Cathia
    Tubiana, Roland
    Brunet, Christel
    Wirden, Marc
    Katlama, Christine
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (05) : 905 - 908
  • [50] Evolution of protease and reverse transcriptase inhibitor resistance-associated mutations in HIV-1-infected protease inhibitor-treated patients with persistent low viraemia
    Duval, X
    Descamps, D
    Breton, G
    Darmon, S
    Ecobichon, JL
    Delarue, S
    Peytavin, G
    Leport, C
    Vildé, JL
    Brun-Vézinet, F
    ANTIVIRAL THERAPY, 2005, 10 (01) : 197 - 199